An independent laboratory can report healthy collections and still leave meaningful reimbursement on the table. A growing accounts receivable balance, rising payer edits, delayed credentialing, or an unresolved medical necessity pattern can reduce cash flow long before the issue is visible in a monthly financial statement. The best RCM audit metrics give laboratory leaders an earlier, clearer view of where revenue is slowing, leaking, or being lost.
For urine toxicology laboratories and diagnostic testing providers, an effective audit is not a scorecard exercise. It is a management tool. It connects front-end ordering and coverage workflows with charge capture, claim submission, payer response, patient responsibility, and final payment. The goal is not simply to improve a percentage. It is to make smarter long-term decisions that support compliant growth and a more predictable revenue base.
Start With Metrics That Identify Action
Not every revenue cycle metric deserves equal attention. A useful audit metric should answer a practical question: Is the issue occurring before the claim is submitted, during payer adjudication, after denial, or in follow-up?
Laboratory leaders should also avoid treating a single benchmark as a verdict. Payer mix, testing complexity, state requirements, contract terms, and the age of the laboratory all affect what good performance looks like. A specialty toxicology lab with a high Medicaid mix will have a different operating profile than a commercial-pay focused diagnostic lab. The value of an audit comes from comparing performance over time, by payer, test category, location, and denial reason.
1. Clean Claim Rate
Clean claim rate measures the percentage of claims paid on the first submission without manual intervention, correction, or appeal. It is one of the best early indicators of how well registration, eligibility verification, ordering documentation, coding, charge entry, and claim editing are working together.
A declining clean claim rate usually signals a front-end problem, not a collections problem. For laboratories, common causes include missing subscriber information, invalid diagnosis-to-test relationships, incomplete ordering provider data, authorization gaps, and payer-specific billing rule failures.
Review this metric by payer rather than only in aggregate. A 95% overall rate can conceal a serious issue with one high-volume commercial payer. The audit should identify the most frequent edit categories and assign an owner to correct the workflow that produced them.
2. First-Pass Resolution Rate
First-pass resolution rate is closely related to clean claim rate, but it focuses on claims that are fully resolved on the initial submission. That distinction matters. A claim may pass a clearinghouse edit yet later deny because it fails a payer policy or lacks supporting documentation.
For toxicology screening providers, this metric can expose recurring friction around medical necessity, frequency limitations, modifier use, and ordering documentation. When the rate falls, leaders should look beyond billing staff productivity. The root cause may sit with requisition design, client education, payer policy monitoring, or an outdated charge master.
3. Denial Rate and Denial Prevention Rate
A total denial rate tells you how many claims are denied, but it does not tell you whether the denials were avoidable. A stronger audit separates denials into preventable and non-preventable categories.
Preventable denials are typically caused by internal process failures, such as eligibility errors, missing authorization, duplicate billing, timely filing misses, coding inaccuracies, or incomplete documentation. Non-preventable denials may result from a payer policy change, a contractual dispute, or a coverage decision requiring appeal.
This separation protects the team from chasing the wrong solution. If most denials are preventable, the priority is process correction and accountability. If denials are driven by a small number of payer policies, the laboratory may need updated client guidance, a contract review, or a more disciplined appeal strategy.
Track denial dollars as well as denial volume. A low-volume denial category can still create a major financial impact if it affects higher-value testing.
4. Net Collection Rate
Net collection rate measures how much of the allowable reimbursement the laboratory actually collects after contractual adjustments. It is one of the most meaningful indicators of whether earned revenue is reaching the bank.
A weak net collection rate can point to unworked denials, underpayments, missed secondary billing, inaccurate contractual adjustments, or poor follow-up on patient balances. It can also reveal that expected allowables are not being maintained accurately in the billing system.
This metric is most useful when calculated by payer and service line. If a payer’s collection rate drops while volume remains stable, the laboratory should investigate whether reimbursements changed, claims are being adjusted incorrectly, or underpayments are going unidentified.
5. Gross Collection Rate
Gross collection rate compares total payments against total charges. It has limits because charge structures vary widely and may not reflect contracted reimbursement. Still, it can be useful as a directional measure when viewed alongside net collection rate.
If gross collections decline sharply but net collections remain steady, a charge master change may be the explanation. If both decline, the issue is more likely operational or payer-related. The metric should prompt questions, not create false alarms.
6. Days in Accounts Receivable
Days in A/R estimates how long it takes the laboratory to convert billed charges into cash. Rising days in A/R can pressure payroll, vendor payments, growth investments, and the laboratory’s ability to forecast with confidence.
The total figure matters, but aging detail matters more. A/R should be segmented into current, 31-60, 61-90, 91-120, and over 120-day buckets. It should also be analyzed by payer, client, and denial category.
For an independent lab, a growing over-90 balance is often more concerning than a modest increase in total days. Older receivables become harder to collect and may indicate ineffective work queues, delayed documentation retrieval, slow appeal processes, or timely filing risk.
7. A/R Over 90 Days
A/R over 90 days measures the portion of outstanding receivables that has remained unpaid for more than three months. This is a direct test of follow-up discipline and escalation management.
An audit should identify whether the oldest balances are collectible, appealable, pending documentation, or appropriate for write-off. Keeping uncollectible balances open makes performance look better temporarily, but it distorts financial planning and hides the real value of receivables.
The right threshold depends on the lab’s payer mix and claim complexity. What matters most is a consistent downward trend, supported by documented follow-up activity and clear escalation paths for high-dollar claims.
8. Underpayment Recovery Rate
Many laboratories audit denials but overlook underpayments. That leaves revenue on the table when a payer pays less than the contracted or expected allowable amount.
Underpayment recovery rate measures the percentage of identified underpayments that are successfully corrected and collected. It requires accurate contract terms, current fee schedules, and a process for comparing payment against expected reimbursement.
This metric is particularly valuable for laboratories with multiple payer contracts, evolving test menus, and varying reimbursement methodologies. It also supports better contract conversations because it turns anecdotal concerns into documented financial evidence.
9. Credentialing and Enrollment Readiness
Credentialing is often treated as a separate administrative task, but it has a direct revenue cycle impact. If a billing provider, laboratory location, or payer enrollment record is incomplete or expired, claims may deny or payment may be delayed.
Audit the percentage of active providers, locations, and payer enrollments with current documentation and renewal dates tracked well in advance. Review denied claims for enrollment-related reasons and measure the time required to resolve each issue.
For growing diagnostic labs, this metric is especially valuable when expanding service areas, adding ordering relationships, or entering new payer networks. Revenue growth cannot be sustained if enrollment processes lag behind operations.
Turn Findings Into a Revenue Improvement Plan
The best RCM audit metrics work together. A rising denial rate paired with lower first-pass resolution points toward a submission or documentation issue. Rising days in A/R with stable clean claims may indicate follow-up weakness or payer payment delays. A stable collection rate with poor underpayment recovery may signal that the laboratory is collecting most claims but accepting less than it has earned.
Set a regular audit cadence, typically monthly for operational metrics and quarterly for deeper payer, contract, and workflow reviews. Keep the review focused on a manageable number of corrective actions. Assign each action to a specific owner, set a due date, and measure whether the change improved the next reporting cycle.
Revenue Management Corporation approaches RCM as part of the laboratory’s broader business performance, not a back-office task in isolation. The strongest audit process connects billing results with credentialing, payer strategy, client workflows, and the patient financial experience.
A metric only creates value when it leads to a better decision. For laboratory leaders, the next useful step is to identify the one measure that most clearly explains delayed cash today, then follow that signal back through the workflow until the source is corrected.
Recent Comments